drugset
drugset / Trial / NCT02408055

ADME Study in Healthy Male Subjects With TA-8995

NCT02408055 ↗

Phase 1 Completed 6 enrolled Xention Ltd
NaSingle-groupOpen-labelTreatment

Summary

A study to measure the absorption, metabolism and excretion of a single dose of radiolabelled TA-8995 (10mg) in healthy male subjects.

Timeline

Start
2015-06
Primary completion
2015-08
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Obicetrapib Small molecule 10 mg —

Indications

hyperlipidemia